Daily Archives: June 27, 2011

Featured Stories

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Dozens Receive Nonsterile Simulated Saline Solution


The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

New York Property Owners Challenge Binghamton Fracking Ban

According to a Reuters report, the landowners believe the Binghamton, N.Y., city council and Mayor acted against proper protocol when voting to ban fracking drilling the the city. Instead, they feel the city should have consulted with the Broome County Planning Commission before approving the ban.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

Endocet 325 mg Bottles May Contain Wrong Tablets, Recall Issued

Endo Pharmaceuticals has just issued a nationwide, consumer level recall of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Endocet® tablets, the U.S. Food and Drug Administration (FDA), announced. Endocet® tablets—an oxycodone/acetaminophen formulation—(USP tablets) involved are distributed as 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot … Continue reading

Posted in Pharmaceuticals, Product Recalls |

Metal-on-Metal Hip Implants: Another Medical Innovation That Didn’t Deliver

Newer isn’t always better when it comes to medical products, according to a report from The New York Times. Too often, once they are on the market, it becomes clear that “innovative” drugs and devices provide no more benefits and … Continue reading

Posted in Defective Medical Devices |

Idaho Salmonella Outbreak Tied to Sprouts

Consumers are being warned by public health officials in Idaho to throw out alfalfa sprouts from Evergreen Produce of Moyie Springs, over a potential outbreak of the < "http://www.yourlawyer.com/practice_areas/food_poisoning">Salmonella pathogen. The Bonner County Daily Bee reports that the Idaho Department … Continue reading

Posted in Food Poisoning, Salmonella |

Food, Water Watchdog Calls for Fracking Ban

Hydraulic fracturing—popularly known as fracking—is, in fact, an environmentally threatening method of extracting shale gas that involves injecting a cocktail of fluids, including dangerous, carcinogenic chemicals, into the ground at high pressure to shake gas and oil deposits loose. With … Continue reading

Posted in Hydraulic Fracturing / Fracking |

Cantaloupe Sold at Sams Clubs Recalled for Possible Salmonella

Another contaminated cantaloupe recall has been announced. The U.S. Food and Drug Administration (FDA) repots that this cantaloupe recall involved cantaloupes produced by Eagle Produce, LLC of Scottsdale, Arizona and involves a limited recall of certain cantaloupes shipped from Arizona … Continue reading

Posted in Food Poisoning, Salmonella |

Actos, Avandia Linked to Higher Incidence of Eye Disorder

< "http://www.yourlawyer.com/topics/overview/actos">Actos and < "http://www.yourlawyer.com/topics/overview/avandia">Avandia increase the risk that users will develop diabetic macular edema, a serious eye disorder that can lead to blindness. According to a study presented at the American Diabetes Association’s annual meeting in San Diego, people … Continue reading

Posted in Actos, Avandia, Pharmaceuticals |

Experimental Diabetes Drug Raises Certain Cancer Risks

Bristol-Myers Squibb and AstraZeneca are developing a new diabetes medication, but the experimental drug, although found to be effective in the two-year study, left participants with increased bladder and breast cancers, said Reuters. Of the < "http://www.yourlawyer.com/practice_areas/defective_drugs">dapagliflozin studies completed, 1.4 … Continue reading

Posted in Pharmaceuticals |

Promise of Fracking Falling Short, Report Claims

Hydraulic fracturing, or fracking, has long been touted as the answer to U.S. energy woes. Boosters claim fracking provides a cheap and easy way to tap vast and previously unreachable natural gas deposits trapped in shale rock formations. But according … Continue reading

Posted in Hydraulic Fracturing / Fracking |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.